Tiago Girao
Chief Financial Officer · Immunovant, Inc.
IndividualSelling only
- 2026
- Jul 24, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Tiago Girao files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew J. Fromkin - $7.96M in IMVT purchases and sales in the last 12 months
- Jay S. Stout - $2.34M in IMVT purchases and sales in the last 12 months
- Melanie Gloria - $1.67M in IMVT purchases and sales in the last 12 months
- Tuyl Christopher van - $1.17M in IMVT purchases and sales in the last 12 months
- Eric Venker - $581K in IMVT purchases and sales in the last 12 months
- Atul Pande - $425K in IMVT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Tiago Girao?
Tiago Girao is a corporate insider, tracked as Chief Financial Officer of Immunovant, Inc. (IMVT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Tiago Girao submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Tiago Girao been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($1.41M) across all tracked filings.
